Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Clinical Trials

Brexit Realities

| James Strachan

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors – not least tight timelines and a limited ability to stockpile.

Business & Regulation Business Practice

Fourth Time’s a Charm

| James Strachan

Sitting Down With… Nigel Theobald, Chief Executive, N4 Pharma. He tells us the story of his career, the challenges (and advantages) of having an economics background, and offers some advice for budding life-science entrepreneurs.

Manufacture Advanced Medicine

Logistics Will Prevail

| Sam Herbert

Sam Herbert from World Courier argues that early collaboration between couriers and manufacturers will be key to overcoming the logistical challenges presented by advanced therapies. Fortunately, history is on our side.

Register to personalize your newsfeed

Create Account

Latest Articles

Business & Regulation Business Practice

Expect the Unexpected

| Yong Guo

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

Business & Regulation Supply Chain

The Road to Interoperability

| Maryam Mahdi

The FDA has accepted TraceLink's blockchain and digital recall projects into its DSCSA Pilot Program.

Business & Regulation Business Practice

Business in Brief

| Maryam Mahdi

Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Gene finds that the pressures of viral vector manufacturing are almost too much.

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Fail to Prepare? Prepare to Fail…

Manufacture Contract Manufacturing Services

The Customer View

| Sponsored by Millipore Sigma

Samsung Biologics give their opinion on working with the M Lab™ Collaboration Centers.

Manufacture Bioprocessing - Upstream & Downstream

Single-Pass Promise

| Torsten Bisschop, Matteo Costioli

When EMD Serono wanted to increase drug production, they found that their manufacturing process did not have the required capacity.

Business & Regulation Business Practice

How to Commercialize an Orphan Drug

| George A. Chressanthis, Animesh Arun

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Manufacture Contract Manufacturing Services

Welcome to the M Lab™ Collaboration Centers!

| Chin Bin Tan

Enter a space where you can explore new ideas, learn innovative techniques, and work side by side with technical experts

Manufacture Standards & Regulation

Quality, Not Quantity

| Iain Moore

Qualitative risk assessments are a great way to approach quality management and train your operators at the same time.

All Articles

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Upcoming Events

-

14th International Conference on Biologics and Biosimilars

Chicago, USA

14th International Conference on Biologics and Biosimilars is scheduled to held on August 2-3, 2019 in Chicago, USA. On...

-

Pathology Horizons Conference

Queenstown, Australia

Pathology Horizons is an annual CPD conference organised by Cirdan that focuses on the future of pathology. Delegates...

-

BioManufacturing Conference

Munich, Germany

The conference will provide a forum to present innovative approaches and discuss hot topics related to product, process...

All Events

Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Total virus titer in minutes

| Contributed by Malvern Panalytical

All White Papers

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register